Introduction {#sec1}
============

Carbohydrates play an important role in life science^[@ref1],[@ref2]^ and related fields such as medicinal chemistry and pharmaceuticals^[@ref3]^ because carbohydrate-derived drugs are used clinically and glycosylations are an important tool in drug discovery.^[@ref4]^ Thus, glycosylations are one of the most important research topics in carbohydrate chemistry.^[@ref5]^ As a result, a myriad of chemical glycosylation methods have been developed.^[@ref6]−[@ref12]^ These methods are adapted for various glycosylation purposes by using different pairs of catalysts or promoters with an appropriate anomeric leaving group. Some well-known pairs include BF~3~/trichloroacetimidate,^[@ref13]^ NIS-TMSOTf or AgOTf/alkyl- or arylthio,^[@ref14],[@ref15]^ IDCP/pentenyl,^[@ref16],[@ref17]^ and AgOTf/halides.^[@ref18]^ The wide variety of leaving groups and catalyst or promoter pairs has made it possible to carry out chemoselective glycosylations as well as multistep glycosylations to obtain complex oligosaccharides^[@ref19]−[@ref21]^ and one-pot synthesis of tris- or tetrasaccharides.^[@ref22]−[@ref24]^ However, it continues to be important to further broaden the scope of leaving groups and catalyst or promoter pairs.

Classically, when these reactions are promoted by strong Lewis acids such as BF~3~^[@ref25]^ or SnCl~4~,^[@ref16]^ the acceptors used are more than 4 equiv. However, HClO~4~-catalyzed glycosylations have been reported to require only 1.2 equiv of donors.^[@ref26]^ Most of the other research have focused on employing functionalized acyloxy leaving groups including glycosyl phthalates,^[@ref27],[@ref28]^ glycosyl *o*-methoxybenzoates,^[@ref29]^ and glycosyl alkynylbenzoates,^[@ref30],[@ref31]^ catalyzed by SnCl~3~ClO~4~,^[@ref28]^ Ph~3~PAuOTf,^[@ref30],[@ref31]^ PhCCH/AuCl~3~,^[@ref32]^ and TMSOTf.^[@ref27],[@ref29],[@ref33]−[@ref36]^ In most of these cases, the glycoside yields are excellent, but catalysts such as TMSOTf or AgOTf are very expensive and moisture-sensitive, or they contaminate the products with metals. In addition, low-temperature conditions are often required to conduct these reactions, and this is not cost-effective in terms of energy and equipment. These have somewhat restricted the use of these methods, especially in the pharmaceutical industry. Our research is aimed at the development of economic glycosylations using anomeric acyloxy carbohydrates as donors with an inexpensive promoter. To this end, we have developed a promoter system consisting of MeSCH~2~Cl/KI, which is capable of activating the anomeric benzoloxy of a carbohydrate donor for glycosylations. The results are reported herein.

Results and Discussion {#sec2}
======================

Crystalline β-glycosyl benzoate **1a**, which can be prepared quantitatively according to our recently published method,^[@ref37]^ was selected as the carbohydrate donor, and lauryl alcohol (**2a**) was selected as the acceptor ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Cyanuric chloride-activated dimethyl sulfoxide (DMSO) has been investigated as a precatalyst in several synthetic methods,^[@ref38]−[@ref41]^ and it has been shown to have Lewis acid properties. Therefore, cyanuric chloride and DMSO were used to promote the glycosylation between **1a** and **2a** in acetonitrile (MeCN) at 80 °C. The reaction gave glycoside **3a** in 10% yield. A nuclear magnetic resonance (NMR) analysis of the reaction product of cyanuric chloride and DMSO showed the presence of MeSCH~2~Cl. This compound was also reported by Knorr in the reaction between acyl chloride and DMSO.^[@ref42]^ On the basis of this, a mixture of **1a** and **2a** (1.0 equiv each) was treated with MeSCH~2~Cl (2.5 equiv) and KI (0.7 equiv) in MeCN (2 mL) at room temperature and at 45 °C, but no glycosylations occurred ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1 and 2). However, to our delight, elevating the temperature to 80 °C produced **3a** in 35% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3), and increasing the amount of glycosyl ester to 1.9 equiv raised the yield to 46% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). Using KI, NaI, or tetrabutyl ammonium iodide (TBAI) determined that KI is the optimal source of I^--^ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 4--6). Various solvents including MeCN, dichloroethane (DCE), tetrahydrofuran (THF), toluene, chloroform, ethyl acetate, and DMSO were screened, and the results indicated that toluene is the optimal solvent ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 7--12). A 73% yield was obtained with toluene ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 12). Changing the amount of toluene from 1 to 4 mL did not affect the results ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 13 and 14). In summary, the optimized conditions were 1.9 equiv of β-glycosyl benzoate **1a** and 1.0 equiv of lauryl alcohol (**2a**) promoted by 2.5 equiv of MeSCH~2~Cl and 0.7 equiv of KI, with 4 Å molecular sieves (MS) in toluene (2 mL) at 80 °C under N~2~.

###### Optimization of Glucosylation Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-00729d_0007){#GRAPHIC-d78e369-autogenerated}

  entry   **1a** (equiv)   I^--^   solvent          temperature (°C)   yield (%)[b](#t1fn2){ref-type="table-fn"}   α/β
  ------- ---------------- ------- ---------------- ------------------ ------------------------------------------- ------
  1       1.0              KI      MeCN (2 mL)      r.t.               NR[c](#t1fn3){ref-type="table-fn"}           
  2       1.0              KI      MeCN (2 mL)      45                 NR[c](#t1fn3){ref-type="table-fn"}           
  3       1.0              KI      MeCN (2 mL)      80                 35                                          3:2
  4       1.9              KI      MeCN (2 mL)      80                 46                                          3:2
  5       1.9              NaI     MeCN (2 mL)      80                 40                                          6:5
  6       1.9              TBAI    MeCN (2 mL)      80                 NR[c](#t1fn3){ref-type="table-fn"}           
  7       1.9              KI      DCE (2 mL)       80                 38                                          6:5
  8       1.9              KI      THF (2 mL)       80                 25                                          8:3
  9       1.9              KI      DMSO (2 mL)      80                 NR[c](#t1fn3){ref-type="table-fn"}           
  10      1.9              KI      CHCl~3~ (2 mL)   80                 71                                          13:5
  11      1.9              KI      EA (2 mL)        80                 70                                          14:5
  12      1.9              KI      toluene (2 mL)   80                 73                                          4:1
  13      1.9              KI      toluene (1 mL)   80                 73                                          4:1
  14      1.9              KI      toluene (4 mL)   80                 73                                          4:1

Reaction conditions: β-glucosyl ester **1a**, lauryl alcohol (**2a**, 1.0 equiv), MeSCH~2~Cl: 2.5 equiv, KI: 0.7 equiv, and 4 Å MS under N~2~ at 80 °C.

Isolated yield.

NR, no reaction.

Under the optimized condition, 11 glucosylations were performed, among which 3 products were disaccharides ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, **3f**, **3g**, and **3e**). The carbohydrate acceptor with a primary hydroxyl group gave a better yield than the acceptor with a secondary one (**3f** vs **3h**). The yields were lower for the nitrogen-containing (**3c**) and tertiary alcohol (**3e**) acceptors. The best yield was achieved for **3j** (79%), starting from a steroid acceptor with a secondary hydroxyl group.

![Expanding the Substrate Scope for Glucosylations Using 1.9 equiv of Donor **1a** and Promoted by MeSCH~2~Cl/KI\
Reaction conditions: β-glucosyl ester **1a** (1.9 equiv), acceptor **2** (1.0 equiv), MeSCH~2~Cl: 2.5 equiv, KI: 0.7 equiv, and 4 Å MS under N~2~ at 80 °C.](ao-2017-00729d_0001){#sch1}

These results demonstrate that when glucosylations are promoted by MeSCH~2~Cl/KI, a benzoloxy group at the anomeric center can function as a good leaving group. The advantages of this leaving group are its easy preparation and long-shelf life. In the glycosylations using anomeric acyloxy as the leaving group activated by a strong Lewis acid such as SnCl~4~,^[@ref16]^ an excess amount of a strong acid can activate the glycosidic bond of the product, causing a substitution of the acceptor by the acetoxy group. This can be avoided by using an excess amount of acceptor to drive the glycosylation to completion. The high-cost problems of catalysts for new anomeric esters developed from functionalized acids^[@ref30]−[@ref35]^ can be solved using cheap promoters/catalysts such as MeSCH~2~Cl/KI. MeSCH~2~Cl is readily prepared from the cheap bulk chemicals cyanuric chloride and DMSO,^[@ref43]^ a liquid with a slight garlic odor, bp 105--108 °C. The preparation cost of MeSCH~2~Cl is estimated to be \<\$1/mol compared with \$1741/mol for AgOTf and \$633/mol for TMSOTf. Therefore, this method has obvious cost advantages.

Another advantage of the MeSCH~2~Cl/KI promoter system is that it does not activate the glycosidic bond, and as a result, less than 2 equiv of carbohydrate donor is enough to drive the reaction to completion.

Next, the applicability of this promoter to other leaving groups was explored. As shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, anomeric fluoro donor **1b** gave glucosylated **2f** in 33% yield. Anomeric chloro donor **1c** gave a 42% yield of disaccharide **3f**. Schmidt donor **1e** proved to be almost as effective (61%) as anomeric benzoloxy donor **1a**. Mannosyl donor β-**1f** with an anomeric benzoloxy group was activated to yield **3l** stereoselectively (38%, only α-anomer). All reactions were fast (1--4.5 h). When the leaving group was Br (**1d**), EtS (**1g**), TBDMSO (**1h**), or OH (**1i**), no glycosylations occurred. In addition, with disarmed donors, glycosylations with **2f** all ended in failure. This suggests that armed and disarmed donors can be employed orthogonally^[@ref5]^ in oligosaccharide synthesis when promoted by MeSCH~2~Cl/KI along with other catalyst/promoter systems.

![Expanding the Carbohydrate Donor Scope for Glycosylations Using 1.9 equiv of Donor **1** and Promoted by MeSCH~2~Cl/KI\
Reaction conditions: β-glycosyl donor **1** (1.9 equiv), acceptor **2f** (1.0 equiv), MeSCH~2~Cl: 2.5 equiv, KI: 0.7 equiv, and 4 Å MS under N~2~ at 80 °C.](ao-2017-00729d_0002){#sch2}

The MeSCH~2~Cl/KI-promoted glycosylation with the reactive leaving group was further explored for other acceptors, and better results were obtained using steroid **2j** as the acceptor ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Both glucosyl donors **1c** and **1e** and mannosyl donors α-**1f**, β-**1f**, and **1o** were subjected to the conditions, and most of the yields were around 56--69%. In the case of α-**1f** and β-**1f**, similar yields were obtained (68 and 69%). For all three cases that started from mannosyl donors (α-**1f**, β-**1f**, and **1o**), α-mannoside was stereoselectively obtained. Other methods have been reported for the diastereoselective synthesis of α-mannosylations,^[@ref7],[@ref8]^ but most of them are more expensive than this procedure. Glucosylations of tigogenin (**2k**) using **1c** and **1e** as the glucosyl donors delivered glucoside **3k** with even better yields (74 and 79%, respectively).

![Further Expanding the Carbohydrate Donor Scope for Glycosylations Using **2j** or **2k** as Acceptors Promoted by MeSCH~2~Cl/KI\
Reaction conditions: β-glycosyl ester **1** (1.9 equiv), acceptor **2j** or **2k** (1.0 equiv), MeSCH~2~Cl: 2.5 equiv, KI: 0.7 equiv, and 4 Å MS under N~2~ at 80 °C.](ao-2017-00729d_0003){#sch3}

Finally, the glycosylation acceptor scope was expanded to include nucleosides ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Six glycosylated nucleosides were synthesized, including three glucosylations and three mannosylations. Although the yields for the nucleoside glycosylations are not high (34--47%), this represents a practical procedure with a benzoloxy leaving group that uses less than 2 equiv of donors. It is well-known that direct glycosylations of nucleosides are difficult and excessive amounts of glycosyl donors are necessary. Only one direct glycosylation of nucleosides has previously been reported,^[@ref44]^ which used 1.2 equiv of the donors and was promoted by 1.5 equiv of In(OTf)~3~ to give fair-to-excellent yields of nucleoside disaccharides. However, our method has advantage in terms of cost efficiency because the cost of In(OTf)~3~ is about \$3855/mol compared with \<\$1/mol for MeSCH~2~Cl. In addition, our method avoids the use of toxic heavy metals.

![Direct Glycosylations of Nucleosides Promoted by MeSCH~2~Cl/KI\
Reaction conditions: β-glycosyl ester **1** (1.9 equiv), nucleosides **2n--2p** (1.0 equiv), MeSCH~2~Cl: 2.5 equiv, KI: 0.7 equiv, and 4 Å MS under N~2~ at 80 °C.](ao-2017-00729d_0004){#sch4}

Among the six glycosylated nucleosides, two products started from zidovudine (AZT, a nucleoside), the first clinical drug used to treat HIV.^[@ref45]^ For the first time, AZT was successfully glucosylated (**3r**) and mannosylated (**3s**). Bioassays of these two products will be conducted.

A proposed mechanism for glycosylation is shown in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}. Chloromethyl methyl sulfide is in equilibrium or in resonance with sulfonium ion **A**, which is capable of associating with the sp^2^ oxygen atom of ester **1a**, but cannot effectively associate with sp^3^ oxygen atoms. Intermediate **B** forms from the activation of **1a** by **A**, and then, **B** decomposes to **D** and glycosyl cation **C**. Trapping glycosyl cation **C** with the carbohydrate acceptor ROH leads to glycoside **3**. The reason that more than 2 equiv of chloromethyl methyl sulfide is required is probably because more BzOCH~2~SMe (**E**) is formed from **D** than from **A**, and/or the formation of **E** is irreversible. Therefore, only some of the chloromethyl methyl sulfide functions as the catalyst, and the majority acts as a promoter.

![Proposed Mechanism for the Glycosylation Promoted by MeSCH~2~Cl/KI](ao-2017-00729d_0005){#sch5}

To support the S~N~1-like mechanism involving **C** ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}),^[@ref46]^ a set of reactions between lauryl alcohol and glycosyl ester α/β-**1a** (α/β = 1:2.1) and α/β-**1p** (α/β = 1:2.3) were conducted ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). The two glycosylations resulted in similar α/β ratios (3:1 vs 2.7:1) in diasteroeselectivity, reaction yields (70 vs 72%), and reaction times (4 vs 3 h). This indicates that anomeric benzoloxy and acetoxy function as leaving groups in similar ways. The faster reaction rate of α/β-**1p** (compared with α/β-**1a**) suggests that sulfonium ion **A** is a weak Lewis acid ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}) that activates the stronger Lewis base α/β-**1p** more efficiently. To our knowledge, a sulfonium ion has never been reported as a Lewis acid, although Lewis acid phosphonium and siliconium ions are known.^[@ref47]^ It was reported that the formation of the side product thioacetal from the alcohol oxidation by activated DMSO is attributed to the addition of alcohol to sulfonium ion **A**.^[@ref48]^

![Glucosylations of α/β Donor Mixtures Promoted by MeSCH~2~Cl/KI\
Reaction conditions: β-glucosyl ester **1** (1.9 equiv), lauryl alcohol (**2a**, 1.0 equiv), MeSCH~2~Cl: 2.5 equiv, KI: 0.7 equiv, and 4 Å MS under N~2~ at 80 °C.](ao-2017-00729d_0006){#sch6}

Similar results for pure β-**1a** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) and α/β-**1a** ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}) indicate that mixed acyloxy anomers can be used as carbohydrate donors without the need for separation. This is also supported by the similar performance of mannosyl donors α-**1f** and β-**1f** with acceptor **2f** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). This means that α/β glycosyl ester donor mixtures, which are much easier to prepare than their single anomer counterparts, are applicable to this procedure.

In summary, cost-effective glycosylation reactions with a broad spectrum of anomeric leaving groups have been achieved using a new promoter. This organo-promoter system can replace many expensive catalysts, some of which contain toxic heavy metals. This promoter is capable of facilitating glycosylations with anomeric benzoloxy donors on various acceptors. A notable result is the first direct glycosylation of a nucleoside using a benzoloxy leaving group in a cost-effective and heavy metal-free way. This practical method is attractive to industries for reducing the costs of expensive catalysts and low-temperature equipment. The mechanism of glycosylation has been discussed.

Experimental Section {#sec3}
====================

General Information {#sec3-1}
-------------------

Commercially available reagents were used without further purification. The starting materials **1a**,^[@ref37]^**1c--1o**,^[@ref49]−[@ref57]^**2c**,^[@ref58]^**2f**,^[@ref59]^**2g**,^[@ref54]^**2h**,^[@ref60]^**2n--2o,**^[@ref54]^ and MeSCH~2~Cl^[@ref43]^ were prepared according to the literature. ^1^H NMR and ^13^C NMR spectra were recorded with a 400 or 600 MHz spectrometer using tetramethylsilane (TMS) as an internal standard. Chemical shifts (δ) are reported relative to TMS (^1^H) or CDCl~3~ (^13^C). High-resolution mass spectra (HRMS) were recorded on a quadrupole time-of-flight (QTOF) mass analyzer using electrospray ionization (ESI).

Procedure for the Synthesis of **1a** {#sec3-2}
-------------------------------------

A mixture of 2,3,4,6-tetra-*O*-benzyl-α-[d]{.smallcaps}-glucopyranosyl chloride (300 mg), benzoic acid (1.05 equiv, 69 mg), Cs~2~CO~3~ (0.51 equiv, 89 mg), tetrabutyl ammonium bromide (TBAB, 0.05 equiv, 9 mg), and granular polytetrafluoroethylene (PTFE) sand (5 g) was mechanically stirred (400 rpm) at 80 °C for 2 min, followed by the addition of water (10 equiv, 97 mg). Initially, the reaction media appeared as thick milk, and it gradually turned to a semisolid that adhered to the glass. After thin-layer chromatography (TLC) indicated completion of the reaction, ethyl acetate (2 × 10 mL) was added to extract the crude product, which was washed with 5% aqueous Na~2~CO~3~ (1 × 10 mL) and water (1 × 10 mL) and dried over Na~2~SO~4~. Concentration under reduced pressure gave 2,3,4,6-tetra-*O*-benzyl-β-[d]{.smallcaps}-glucopyranosyl benzoate **1a** (351 mg, \>99%).

General Procedure for Glycosylation Using the Glycosylation of **2a** as an Example {#sec3-3}
-----------------------------------------------------------------------------------

To a solution of **2a** (0.5 mmol, 93 mg) in dry toluene (2 mL) were added **1a** (0.95 mmol, 612 mg), MeSCH~2~Cl (2.5 mmol, 120 mg), KI (0.35 mmol, 58 mg), and 4 Å MS. The mixture was stirred at 80 °C under N~2~ (monitored by TLC). After completion, the reaction mixture was quenched with 5% aqueous Na~2~CO~3~ (10 mL) and extracted with dichloromethane (DCM) (2 × 10 mL). The combined organic layers were washed with water (10 mL) and brine (10 mL), dried over Na~2~SO~4~, and evaporated under vacuum. The residue was purified by chromatography to yield **3a** (89 mg, 73%).

### *n*-Dodecyl 2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranoside (**3a**)^[@ref61]^ {#sec3-3-1}

Method A: starting from β-glucosyl ester **1a** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). β-Glucosyl ester **1a** (0.95 mmol, 612 mg) and alcohol **2a** (0.5 mmol, 93 mg) were reacted according to the general procedure. After chromatography, glucoside **3a** was isolated as a syrup (258 mg, 73% yield, α/β = 4/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.42--7.09 (m, 25H), 4.99 (d, *J* = 10.8 Hz, 1H), 4.93 (d, *J* = 10.8 Hz, 0.5H), 4.89--4.73 (m, 4H), 4.72 (d, *J* = 11.0 Hz, 0.5H), 4.62 (dd, *J* = 24.6, 11.3 Hz, 2.5H), 4.46 (dd, *J* = 11.2, 2.8 Hz, 2H), 4.39 (d, *J* = 7.5 Hz, 0.5H), 3.99 (t, *J* = 9.3 Hz, 1.25H), 3.77 (d, *J* = 10.4 Hz, 1H), 3.73 (dd, *J* = 10.4, 3.2 Hz, 1H), 3.69--3.59 (m, 3.25H), 3.55 (dd, *J* = 9.6, 3.6 Hz, 1.5H), 3.48--3.37 (m, 1.5H), 1.71--1.58 (m, 2.5H), 1.26 (s, 22.5H), 0.88 (t, *J* = 6.6 Hz, 3.75H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.4, 138.3, 138.0, 128.4, 128.2, 128.1, 128.0, 127.98, 127.88, 127.82, 127.75, 127.6, 96.9, 82.2, 80.1, 77.8, 75.8, 75.2, 74.9, 73.5, 73.2, 70.1, 68.5, 68.3, 29.7, 29.5, 26.3, 22.8, 14.2.

Method B: starting from α/β-glucosyl ester **1a** (α/β = 1/2.1) ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). α/β-Glucosyl ester **1a** (0.95 mmol, 612 mg) and alcohol **2a** (0.5 mmol, 93 mg) were reacted according to the general procedure. After chromatography, glucoside **3a** was isolated as a syrup (248 mg, 70% yield, α/β = 3/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.42--7.09 (m, 26H), 4.99--3.37 (m, 22H), 1.71--1.58 (m, 2.6H), 1.26 (s, 23H), 0.88 (t, *J* = 6.6 Hz, 3.9H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.4, 138.3, 138.0, 128.4, 128.2, 128.1, 128.0, 127.98, 127.88, 127.82, 127.75, 127.6, 96.9, 82.2, 80.1, 77.8, 75.8, 75.2, 74.9, 73.5, 73.2, 70.1, 68.5, 68.3, 29.7, 29.5, 26.3, 22.8, 14.2.

Method C: starting from α/β-glucosyl ester **1p** (α/β = 1/2.3) ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). α/β-Glucosyl ester **1p** (0.95 mmol, 553 mg) and alcohol **2a** (0.5 mmol, 93 mg) were reacted according to the general procedure. After chromatography, glucoside **3a** was isolated as a syrup (248 mg, 72% yield, α/β = 2.7/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.42--7.09 (m, 27H), 4.99--3.37 (m, 23H), 1.71--1.58 (m, 2.7H), 1.26 (s, 24H), 0.88 (t, *J* = 6.6 Hz, 4H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.4, 138.3, 138.0, 128.4, 128.2, 128.1, 128.0, 127.98, 127.88, 127.82, 127.75, 127.6, 96.9, 82.2, 80.1, 77.8, 75.8, 75.2, 74.9, 73.5, 73.2, 70.1, 68.5, 68.3, 29.7, 29.5, 26.3, 22.8, 14.2.

### *n*-Cyclohexyl 2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranoside (**3b**)^[@ref62],[@ref63]^ {#sec3-3-2}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and alcohol **2b** (0.5 mmol, 50 mg) were reacted according to the general procedure. After chromatography, glucoside **3b** was isolated as a syrup (168 mg, 54% yield, α/β = 3.5/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.41--7.09 (m, 26H), 5.00 (d, *J* = 10.8 Hz, 1.3H), 4.97--4.89 (m, 1.3H), 4.86--4.77 (m, 2.6H), 4.77--4.56 (m, 4H), 4.56--4.49 (m, 0.6H), 4.49--4.43 (m, 2H), 4.00 (t, *J* = 9.3 Hz, 1H), 3.88 (d, *J* = 9.0 Hz, 1H), 3.74 (dd, *J* = 10.6, 3.8 Hz, 1.6H), 3.69--3.60 (m, 2.6H), 3.60--3.49 (m, 2.3H), 3.45 (dd, *J* = 13.8, 5.9 Hz, 0.6H), 2.07--1.80 (m, 2.6H), 1.80--1.69 (m, 2.6H), 1.51--1.13 (m, 6.9H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.1, 138.4, 138.3, 138.1, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.96, 127.88, 127.79, 127.75, 127.72, 127.6, 102.0, 94.7, 84.9, 82.2, 80.0, 78.1, 77.9, 75.7, 75.3, 75.2, 75.1, 74.92, 74.87, 73.5, 73.0, 70.1, 68.6, 33.9, 33.4, 32.1, 31.5, 25.7, 24.6, 24.3.

### (4*S*)-\[(2′,3′,4′,6′-Tetra-*O*-benzyl-β-[d]{.smallcaps}-glucopyranosyl)oxy\]-1-\[(4-methylphenyl)sulfonyl\]-[l]{.smallcaps}-proline (**3c**) {#sec3-3-3}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and amino acid **2c** (0.5 mmol, 143 mg) were reacted according to the general procedure. After chromatography, glucoside **3c** was isolated as a syrup (117 mg, 29% yield, α/β = 5/1); ^1^H NMR (400 MHz, CDCl~3~): δ 8.45 (s, 1.2H), 7.79 (d, *J* = 7.9 Hz, 2H), 7.45--7.10 (m, 26H), 4.93 (d, *J* = 10.8 Hz, 1.2H), 4.89--4.70 (m, 4H), 4.68 (d, *J* = 5.7 Hz, 0.2H), 4.60 (t, *J* = 11.2 Hz, 2.2H), 4.50--4.41 (m, 2H), 4.40 (d, *J* = 5.8 Hz, 0.2H), 4.36--4.28 (m, 1H), 4.20 (t, *J* = 7.1 Hz, 1H), 3.85 (dd, *J* = 10.3, 5.2 Hz, 1H), 3.76--3.53 (m, 4.4H), 3.49 (dd, *J* = 8.9, 3.2 Hz, 1H), 3.44 (d, *J* = 9.1 Hz, 1H), 3.39 (dd, *J* = 10.4, 2.9 Hz, 1H), 2.40--2.35 (m, 0.4H), 2.30 (d, *J* = 7.1 Hz, 2H), 2.23 (s, 2.2H), 2.10 (s, 1.4H); ^13^C NMR (101 MHz, CDCl~3~): δ 177.0, 143.9, 138.8, 138.2, 138.1, 137.9, 129.9, 128.6, 128.5, 128.4, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 97.5, 81.7, 79.8, 75.6, 75.2, 73.5, 73.2, 70.9, 68.1, 60.5, 53.9, 37.1, 21.5; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~46~H~49~NO~10~SNa^+^ 830.2969; found 830.2969.

### [l]{.smallcaps}-Menthyl 2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranoside (**3d**)^[@ref64],[@ref65]^ {#sec3-3-4}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and alcohol **2d** (0.5 mmol, 78 mg) were reacted according to the general procedure. After chromatography, glucoside **3d** was isolated as a syrup (234 mg, 69% yield, α/β = 5/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.39--7.05 (m, 22H), 5.06--4.95 (m, 2H), 4.93 (d, *J* = 10.8 Hz, 0.4H), 4.83 (dd, *J* = 10.8, 5.1 Hz, 2.4H), 4.75--4.62 (dt, *J* = 24.0, 12.0 Hz, 3.2H), 4.56 (dd, *J* = 16.2, 11.9 Hz, 0.6H), 4.46 (dd, *J* = 11.4, 7.9 Hz, 2.2H), 4.00 (dd, *J* = 20.8, 11.0 Hz, 2H), 3.75 (dd, *J* = 10.4, 3.3 Hz, 1H), 3.69 (d, *J* = 2.4 Hz, 0.4H), 3.67--3.58 (m, 2.4H), 3.55 (dd, *J* = 9.8, 3.3 Hz, 1H), 3.51--3.40 (m, 0.6H), 3.35 (td, *J* = 10.6, 4.1 Hz, 1H), 2.48--2.36 (m, 1.2H), 2.12 (d, *J* = 11.8 Hz, 1.2H), 1.71--1.55 (m, 2.8H), 1.44--1.20 (m, 3.4H), 1.10--0.74 (m, 12H), 0.70 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.5, 138.4, 138.1, 128.44, 128.43, 128.36, 128.2, 128.0, 127.9, 127.7, 127.6, 98.7, 85.0, 82.1, 81.0, 80.6, 78.1, 75.6, 75.2, 73.5, 73.2, 70.4, 68.7, 48.8, 43.1, 34.3, 31.8, 24.6, 23.0, 22.4, 21.2, 16.2.

### 1′-Adamantyl 2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranoside (**3e**)^[@ref66]^ {#sec3-3-5}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and alcohol **2e** (0.5 mmol, 76 mg) were reacted according to the general procedure. After chromatography, glucoside **3e** was isolated as a syrup (138 mg, 41% yield, α/β = 1.5/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.43--7.05 (m, 33H), 5.28 (d, *J* = 3.6 Hz, 1H), 5.05--4.95 (m, 1.67H), 4.91 (d, *J* = 10.9 Hz, 0.67H), 4.86--4.77 (m, 2.67H), 4.74 (d, *J* = 12.3 Hz, 0.67H), 4.71--4.61 (m, 3H), 4.61--4.50 (m, 2H) (β), 4.47 (d, *J* = 5.0 Hz, 1H), 4.44 (d, *J* = 6.5 Hz, 1H), 4.18--3.95 (m, 2H), 3.81--3.70 (m, 1.67H), 3.69--3.58 (m, 3.34H), 3.53 (dd, *J* = 9.6, 3.7 Hz, 1H), 3.49 (d, *J* = 8.4 Hz, 0.67H), 3.44 (dd, *J* = 16.1, 7.9 Hz, 0.67H), 2.14 (s, 5H), 2.04--1.76 (m, 10H), 1.69--1.55 (m, 10H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.2, 138.8, 138.7, 138.5, 138.44, 138.40, 138.3, 138.2, 128.50, 128.49, 128.43, 128.40, 128.37, 128.29, 128.11, 128.09, 128.02, 127.98, 127.89, 127.85, 127.81, 127.73, 127.69, 127.61, 127.59, 96.4, 90.0, 85.2, 82.4, 82.2, 80.2, 78.3, 78.2, 75.9, 75.7, 75.4, 75.2, 75.1, 74.7, 73.6, 73.5, 73.0, 69.8, 69.6, 68.8, 42.9, 42.6, 36.4, 30.8, 30.7.

### 6-*O*-(2′,3′,4′,6′-Tetra-*O*-benzyl-α/β-glucopyranosyl)-(1-6)-1,2:3,4-di-*O*-isopropylidene-α-[d]{.smallcaps}-galactopyranose (**3f**)^[@ref64]^ {#sec3-3-6}

Method A: starting from β-glucosyl ester **1a** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Glucosyl ester **1a** (0.95 mmol, 612 mg) and galactose **2f** (0.5 mmol, 130 mg) were reacted according to the general procedure. After chromatography, glucoside **3f** was isolated as a syrup (242 mg, 62% yield, α/β = 3.3/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.46--7.10 (m, 26H), 5.57 (d, *J* = 5.0 Hz, 0.3H), 5.52 (d, *J* = 5.0 Hz, 1H), 5.05 (d, *J* = 11.1 Hz, 0.3H), 5.02--4.89 (m, 2H), 4.81 (dd, *J* = 10.8, 8.2 Hz, 2.6H), 4.72 (q, *J* = 11.8 Hz, 2.6H), 4.66--4.51 (m, 3.2H), 4.47 (dd, *J* = 11.4, 6.1 Hz, 2.3H), 4.35 (dd, *J* = 7.9, 1.7 Hz, 1H), 4.31 (dd, *J* = 4.9, 2.3 Hz, 1.3H), 4.24 (dd, *J* = 7.9, 1.7 Hz, 0.3H), 4.16 (dd, *J* = 10.6, 3.6 Hz, 0.3H), 4.09 (d, *J* = 7.5 Hz, 0.3H), 4.03 (t, *J* = 6.9 Hz, 1H), 3.98 (t, *J* = 9.3 Hz, 1H), 3.85--3.55 (m, 8.5H), 3.46 (s, 0.6H), 1.53 (s, 3H), 1.50 (s, 0.9H), 1.45 (s, 3.9H), 1.32 (d, *J* = 4.9 Hz, 7.8H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.7, 138.4, 138.0, 128.8, 128.5, 128.3, 128.03, 127.97, 127.91, 127.81, 127.76, 127.6, 127.5, 109.4, 109.3, 108.7, 104.5, 97.1, 96.5, 96.4, 84.6, 82.0, 81.7, 79.8, 77.7, 77.5, 75.7, 75.1, 74.8, 74.4, 73.5, 72.4, 71.5, 70.9, 70.7, 70.3, 69.8, 68.3, 67.4, 66.2, 65.7, 26.3, 26.2, 26.11, 26.08, 25.1, 25.0, 24.7, 24.5.

Method B: starting from α-glucosyl fluoride **1b** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). α-Glucosyl fluoride **1b** (0.95 mmol, 515 mg) and galactose **2f** (0.5 mmol, 130 mg) were reacted according to the general procedure. After chromatography, glucoside **3f** was isolated as a syrup (129 mg, 33% yield, α/β = 3.3/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.51--6.95 (m, 26H), 5.57 (d, *J* = 4.9 Hz, 0.3H), 5.52 (d, *J* = 4.9 Hz, 1H), 5.09--3.41 (m, 28H), 1.53 (s, 3H), 1.50 (s, 1H), 1.45 (s, 3.9H), 1.31 (s, 7.8H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.7, 138.4, 138.0, 128.8, 128.5, 128.3, 128.03, 127.97, 127.91, 127.81, 127.76, 127.6, 127.5, 109.4, 109.3, 108.7, 104.5, 97.1, 96.5, 96.4, 84.6, 82.0, 81.7, 79.8, 77.7, 77.5, 75.7, 75.1, 74.8, 74.4, 73.5, 72.4, 71.5, 70.9, 70.7, 70.3, 69.8, 68.3, 67.4, 66.2, 65.7, 26.3, 26.2, 26.11, 26.08, 25.1, 25.0, 24.7, 24.5.

Method C: starting from α-glucosyl chloride **1c** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). α-Glucosyl chloride **1c** (0.95 mmol, 530 mg) and galactose **2f** (0.5 mmol, 130 mg) were reacted according to the general procedure. After chromatography, glucoside **3f** was isolated as a syrup (164 mg, 42% yield, α/β = 2.7/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.51--6.95 (m, 28H), 5.57 (d, *J* = 4.9 Hz, 0.37H), 5.52 (d, *J* = 4.9 Hz, 1H), 5.09--3.41 (m, 30H), 1.53 (s, 3H), 1.50 (s, 1.11H), 1.45 (s, 4.11H), 1.31 (s, 8.22H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.7, 138.4, 138.0, 128.8, 128.5, 128.3, 128.03, 127.97, 127.91, 127.81, 127.76, 127.6, 127.5, 109.4, 109.3, 108.7, 104.5, 97.1, 96.5, 96.4, 84.6, 82.0, 81.7, 79.8, 77.7, 77.5, 75.7, 75.1, 74.8, 74.4, 73.5, 72.4, 71.5, 70.9, 70.7, 70.3, 69.8, 68.3, 67.4, 66.2, 65.7, 26.3, 26.2, 26.11, 26.08, 25.1, 25.0, 24.7, 24.5.

Method D: starting from α-glucosyl imidate **1e** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). α-Glucosyl imidate **1e** (0.95 mmol, 649 mg) and galactose **2f** (0.5 mmol, 130 mg) were reacted according to the general procedure. After chromatography, glucoside **3f** was isolated as a syrup (238 mg, 61% yield, α/β = 2.2/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.51--6.95 (m, 29H), 5.57 (d, *J* = 4.9 Hz, 0.46H), 5.52 (d, *J* = 4.9 Hz, 1H), 5.09--3.41 (m, 31H), 1.53 (s, 3H), 1.50 (s, 1.38H), 1.45 (s, 4.38H), 1.31 (s, 8.76H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.7, 138.4, 138.0, 128.8, 128.5, 128.3, 128.03, 127.97, 127.91, 127.81, 127.76, 127.6, 127.5, 109.4, 109.3, 108.7, 104.5, 97.1, 96.5, 96.4, 84.6, 82.0, 81.7, 79.8, 77.7, 77.5, 75.7, 75.1, 74.8, 74.4, 73.5, 72.4, 71.5, 70.9, 70.7, 70.3, 69.8, 68.3, 67.4, 66.2, 65.7, 26.3, 26.2, 26.11, 26.08, 25.1, 25.0, 24.7, 24.5.

### Methyl 2,3,4-Tri-*O*-acetyl-6-*O*-(2′,3′,4′,6′-tetra-*O*-benzyl-α/β-[d]{.smallcaps}-glucopyranosyl)-(1-6)-α-[d]{.smallcaps}-glucopyranoside (**3g**)^[@ref67]^ {#sec3-3-7}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and glucoside **2g** (0.5 mmol, 160 mg) were reacted according to the general procedure. After chromatography, glucoside **3g** was isolated as a syrup (206 mg, 49% yield, α/β = 7/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.39--7.10 (m, 22.8H), 5.52--5.40 (m, 1H), 5.06--4.96 (m, 1H), 4.94 (d, *J* = 10.9 Hz, 1.14H), 4.90 (d, *J* = 3.6 Hz, 1.14H), 4.85--4.72 (m, 5H), 4.62 (dd, *J* = 30.6, 12.1 Hz, 1H), 4.46 (dd, *J* = 11.6, 6.7 Hz, 1H), 4.05--3.99 (m, 2H), 3.99--3.90 (m, 2H), 3.82 (d, *J* = 9.2 Hz, 1H), 3.76--3.71 (m, 1H), 3.67 (dd, *J* = 11.4, 7.8 Hz, 2H), 3.63--3.58 (m, 2H), 3.55 (dd, *J* = 9.7, 3.5 Hz, 1H), 3.53--3.47 (m, 1H), 3.36 (s, 3H), 3.30 (s, 0.42H), 2.06 (s, 3.42H), 1.99 (m, 6.84H); ^13^C NMR (101 MHz, CDCl~3~): δ 170.23, 170.17, 169.8, 138.8, 138.5, 138.4, 137.9, 128.5, 128.4, 128.3, 128.0, 127.97, 127.96, 127.82, 127.75, 127.71, 127.6, 97.2, 96.4, 81.8, 79.8, 77.6, 75.6, 74.9, 73.5, 73.1, 71.1, 70.4, 70.3, 69.5, 68.4, 68.1, 66.5, 55.4, 20.81, 20.80.

### Methyl 3-*O*-Benzyl-2-*O*-(2′,3′,4′,6′-tetra-*O*-benzyl-α-glucopyranosyl)-(1-2)-4,6-*O*-methylene-α-[d]{.smallcaps}-glucopyranoside (**3h**) {#sec3-3-8}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and glucoside **2h** (0.5 mmol, 148 mg) were reacted according to the general procedure. After chromatography, glucoside **3h** was isolated as a syrup (135 mg, 33%, α-only); ^1^H NMR (400 MHz, CDCl~3~): δ 7.44--6.97 (m, 25H), 5.09 (d, *J* = 6.2 Hz, 1H), 5.00 (d, *J* = 10.8 Hz, 1H), 4.90 (d, *J* = 3.5 Hz, 1H), 4.88--4.77 (m, 5H), 4.75--4.65 (dd, *J* = 14.1, 11.4 Hz, 2H), 4.61 (d, *J* = 6.3 Hz, 1H), 4.51 (d, *J* = 12.1 Hz, 1H), 4.43 (d, *J* = 10.9 Hz, 1H), 4.26 (d, *J* = 12.1 Hz, 1H), 4.22--4.07 (m, 3H), 4.03 (t, *J* = 9.4 Hz, 1H), 3.80 (dd, *J* = 9.5, 3.6 Hz, 1H), 3.77--3.70 (m, 1H), 3.69--3.63 (m, 1H), 3.57 (dd, *J* = 9.7, 3.6 Hz, 1H), 3.53--3.40 (m, 5H), 3.40--3.25 (m, 2H); ^13^C NMR (101 MHz, CDCl~3~): δ 138.9, 138.7, 138.4, 138.0, 137.9, 128.7, 128.4, 128.3, 128.3, 128.2, 128.1, 128.03, 128.00, 127.9, 127.8, 127.6, 127.5, 97.1, 94.4, 93.8, 82.4, 82.2, 79.1, 77.7, 77.0, 75.7, 75.0, 74.2, 73.2, 73.1, 70.0, 68.8, 68.0, 62.4, 55.1; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~49~H~54~O~11~Na^+^ 841.3558; found 841.3563.

### (3β)-Cholest-5-en-3-yl 2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranoside (**3i**)^[@ref62],[@ref68]^ {#sec3-3-9}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and steroid **2i** (0.5 mmol, 193 mg) were reacted according to the general procedure. After chromatography, glucoside **3i** was isolated as a syrup (205 mg, 45% yield, α/β = 4/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.50--7.02 (m, 25H), 5.38 (s, 0.25H), 5.31 (d, *J* = 4.8 Hz, 1H), 5.04 (d, *J* = 10.8 Hz, 1H), 5.00--4.95 (m, 1.25H), 4.85 (dd, *J* = 10.8, 6.4 Hz, 2.25H), 4.80 (dd, *J* = 11.5, 4.6 Hz, 1.25H), 4.75 (d, *J* = 10.9 Hz, 0.5H), 4.66 (dd, *J* = 16.8, 12.1 Hz, 2.25H), 4.58 (d, *J* = 4.6 Hz, 0.25H), 4.55 (d, *J* = 4.5 Hz, 0.25H), 4.52--4.44 (m, 2.25H), 4.03 (t, *J* = 9.3 Hz, 1H), 3.91 (d, *J* = 9.2 Hz, 1H), 3.77 (dd, *J* = 10.7, 3.6 Hz, 1.25H), 3.72--3.63 (m, 2.75H), 3.58 (dd, *J* = 9.6, 3.5 Hz, 1.25H), 3.49 (dd, *J* = 10.4, 6.2 Hz, 1H), 2.45 (t, *J* = 11.3 Hz, 1.25H), 2.31 (dd, *J* = 13.7, 3.9 Hz, 1.25H), 2.04 (d, *J* = 12.5 Hz, 1.5H), 2.00--1.84 (m, 3.75H), 1.85--1.70 (m, 1.25H), 1.67--1.06 (m, 26H), 1.04 (s, 4H), 0.95 (d, *J* = 6.4 Hz, 4H), 0.90 (dd, *J* = 6.6, 1.5 Hz, 8H), 0.71 (s, 4H); ^13^C NMR (101 MHz, CDCl~3~): δ 140.9, 139.0, 138.3, 138.0, 128.49, 128.46, 128.40, 128.2, 128.1, 128.0, 127.9, 127.79, 127.75, 127.72, 127.6, 121.8, 94.6, 84.9, 82.2, 79.9, 77.9, 76.5, 75.8, 75.2, 73.5, 73.2, 70.1, 68.6, 56.8, 56.2, 50.2, 42.4, 39.9, 39.8, 39.6, 37.2, 36.8, 36.3, 35.9, 32.0, 31.9, 28.3, 28.1, 27.5, 24.4, 23.9, 22.9, 22.6, 21.1, 19.5, 18.8, 11.9.

### (3β,5α)-3-\[(2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranosyl)oxy\]androstan-17-one (**3j**)^[@ref69]^ {#sec3-3-10}

Method A: starting from β-glucosyl ester **1a** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Glucosyl ester **1a** (0.95 mmol, 612 mg) and steroid **2j** (0.5 mmol, 145 mg) were reacted according to the general procedure. After chromatography, glucoside **3j** was isolated as a syrup (321 mg, 79% yield, α/β = 2/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.40--7.11 (m, 30H), 5.00 (d, *J* = 10.7 Hz, 1H), 4.92 (d, *J* = 3.6 Hz, 1.5H), 4.87--4.44 (m, 9H), 3.99 (t, *J* = 9.2 Hz, 1H), 3.87 (d, *J* = 9.9 Hz, 1H), 3.77--3.40 (m, 7H), 2.44 (dd, *J* = 19.3, 8.7 Hz, 1.5H), 2.12--0.88 (m, 30H), 0.86 (s, 4.5H), 0.83 (s, 4.5H), 0.68 (d, *J* = 7.2 Hz, 1.5H); ^13^C NMR (101 MHz, CDCl~3~): δ 221.5, 139.0, 138.3, 138.1, 128.51, 128.48, 128.42, 128.32, 128.26, 128.10, 128.07, 128.01, 127.99, 127.95, 127.81, 127.77, 127.74, 127.6, 102.0, 94.8, 82.2, 80.0, 78.9, 77.9, 76.0, 75.8, 75.2, 73.5, 73.1, 70.1, 68.7, 54.5, 51.5, 47.9, 45.2, 44.8, 36.9, 35.9, 35.8, 35.1, 31.6, 31.0, 28.5, 27.4, 21.9, 20.6, 13.9, 12.4.

Method B: starting from α-glucosyl chloride **1c** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). α-Glucosyl chloride **1c** (0.95 mmol, 530 mg) and steroid **2j** (0.5 mmol, 145 mg) were reacted according to the general procedure. After chromatography, glucoside **3j** was isolated as a syrup (227 mg, 56% yield, α/β = 2/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.40--7.11 (m, 30H), 5.00 (d, *J* = 10.7 Hz, 1H), 4.92 (d, *J* = 3.6 Hz, 1.5H), 4.87--4.69 (m, 4H), 4.68--4.56 (m, 2.5H), 4.57--4.49 (m, 1H), 4.46 (dd, *J* = 11.4, 4.2 Hz, 1.5H), 3.99 (t, *J* = 9.2 Hz, 1H), 3.87 (d, *J* = 9.9 Hz, 1H), 3.77--3.70 (m, 1.5H), 3.67--3.59 (m, 2.5H), 3.59--3.50 (m, 2H), 3.48--3.33 (m, 1H), 2.44 (dd, *J* = 19.3, 8.7 Hz, 1.5H), 2.12--0.88 (m, 30H), 0.86 (s, 4.5H), 0.83 (s, 4.5H), 0.68 (d, *J* = 7.2 Hz, 1.5H); ^13^C NMR (101 MHz, CDCl~3~): δ 221.5, 139.0, 138.3, 138.1, 128.51, 128.48, 128.42, 128.32, 128.26, 128.10, 128.07, 128.01, 127.99, 127.95, 127.81, 127.77, 127.74, 127.6, 102.0, 94.8, 82.2, 80.0, 78.9, 77.9, 76.0, 75.8, 75.2, 73.5, 73.1, 70.1, 68.7, 54.5, 51.5, 47.9, 45.2, 44.8, 36.9, 35.9, 35.8, 35.1, 31.6, 31.0, 28.5, 27.4, 21.9, 20.6, 13.9, 12.4.

Method C: starting from α-glucosyl imidate **1e** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). α-Glucosyl imidate **1e** (0.95 mmol, 649 mg) and steroid **2j** (0.5 mmol, 145 mg) were reacted according to the general procedure. After chromatography, glucoside **3j** was isolated as a syrup (240 mg, 59% yield, α/β = 3.3/1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.40--7.11 (m, 26H), 5.00 (d, *J* = 10.7 Hz, 1H), 4.92 (d, *J* = 3.6 Hz, 1.3H), 4.87--4.44 (m, 8.2H), 3.99 (t, *J* = 9.2 Hz, 1H), 3.87 (d, *J* = 9.9 Hz, 1H), 3.77--3.40 (m, 6.2H), 2.44 (dd, *J* = 19.3, 8.7 Hz, 1.3H), 2.12--0.88 (m, 26H), 0.86 (s, 3.9H), 0.83 (s, 3.9H), 0.68 (d, *J* = 7.2 Hz, 1.3H); ^13^C NMR (101 MHz, CDCl~3~): δ 221.5, 139.0, 138.3, 138.1, 128.51, 128.48, 128.42, 128.32, 128.26, 128.10, 128.07, 128.01, 127.99, 127.95, 127.81, 127.77, 127.74, 127.6, 102.0, 94.8, 82.2, 80.0, 78.9, 77.9, 76.0, 75.8, 75.2, 73.5, 73.1, 70.1, 68.7, 54.5, 51.5, 47.9, 45.2, 44.8, 36.9, 35.9, 35.8, 35.1, 31.6, 31.0, 28.5, 27.4, 21.9, 20.6, 13.9, 12.4.

### (3β,5α,25*S*)-Spirostan-3-yl 2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranoside (**3k**)^[@ref69],[@ref70]^ {#sec3-3-11}

Method A: starting from β-glucosyl ester **1a** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Glucosyl ester **1a** (0.95 mmol, 612 mg) and steroid **2k** (0.5 mmol, 208 mg) were reacted according to the general procedure. After chromatography, glucoside **3k** was isolated as a syrup (281 mg, 60% yield, α/β = 3.3:1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.40--7.10 (m, 26H), 5.00 (d, *J* = 10.8 Hz, 1H), 4.93 (d, *J* = 3.4 Hz, 1.3H), 4.87--4.71 (m, 3.6H), 4.62 (dd, *J* = 19.0, 12.0 Hz, 2.3H), 4.57--4.50 (m, 0.6H), 4.46 (d, *J* = 11.5 Hz, 2H), 4.39 (dd, *J* = 15.0, 7.4 Hz, 1H), 3.99 (t, *J* = 9.3 Hz, 1H), 3.88 (d, *J* = 9.3 Hz, 1H), 3.72 (dd, *J* = 10.5, 3.8 Hz, 1.3H), 3.67--3.60 (m, 2.3H), 3.54 (dd, *J* = 9.7, 3.5 Hz, 2H), 3.47 (dd, *J* = 11.7, 3.9 Hz, 1.6H), 3.39 (q, *J* = 10.7 Hz, 1.3H), 2.03--1.91 (m, 1.3H), 1.91--1.00 (m, 30H), 0.96 (d, *J* = 7.0 Hz, 3.9H), 0.92--0.82 (m, 4H), 0.82 (s, 3.9H), 0.79 (d, *J* = 6.3 Hz, 3.9H), 0.76 (s, 3.9H), 0.64 (d, *J* = 7.7 Hz, 1.3H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.32, 138.31, 138.0, 128.5, 128.41, 128.38, 128.2, 128.1, 128.0, 127.90, 127.87, 127.80, 127.72, 127.69, 127.57, 109.3, 94.8, 82.2, 80.9, 78.0, 77.9, 76.2, 75.7, 75.1, 73.5, 73.1, 70.0, 68.7, 66.9, 62.2, 56.3, 54.3, 45.1, 41.6, 40.6, 40.1, 36.9, 35.8, 35.1, 32.3, 31.8, 31.4, 30.3, 28.8, 28.6, 27.4, 21.1, 17.2, 16.5, 14.6, 12.4.

Method B: starting from α-glucosyl chloride **1c** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). α-Glucosyl chloride **1c** (0.95 mmol, 530 mg) and steroid **2k** (0.5 mmol, 208 mg) were reacted according to the general procedure. After chromatography, glucoside **3k** was isolated as a syrup (347 mg, 74% yield, α/β = 2:1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.40--7.10 (m, 30H), 5.00 (d, *J* = 10.8 Hz, 1H), 4.93 (d, *J* = 3.4 Hz, 1.5H), 4.87--4.50 (m, 7.5H), 4.46 (d, *J* = 11.5 Hz, 2H), 4.39 (dd, *J* = 15.0, 7.4 Hz, 1H), 3.99 (t, *J* = 9.3 Hz, 1H), 3.88 (d, *J* = 9.3 Hz, 1H), 3.76--3.34 (m, 9.5H), 2.03--1.91 (m, 1.5H), 1.91--0.82 (m, 42H), 0.82 (s, 4.5H), 0.79 (d, *J* = 6.3 Hz, 4.5H), 0.76 (s, 4.5H), 0.64 (d, *J* = 7.7 Hz, 1.5H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.32, 138.31, 138.0, 128.5, 128.41, 128.38, 128.2, 128.1, 128.0, 127.90, 127.87, 127.80, 127.72, 127.69, 127.57, 109.3, 94.8, 82.2, 80.9, 78.0, 77.9, 76.2, 75.7, 75.1, 73.5, 73.1, 70.0, 68.7, 66.9, 62.2, 56.3, 54.3, 45.1, 41.6, 40.6, 40.1, 36.9, 35.8, 35.1, 32.3, 31.8, 31.4, 30.3, 28.8, 28.6, 27.4, 21.1, 17.2, 16.5, 14.6, 12.4.

Method C: starting from α-glucosyl imidate **1e** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). α-Glucosyl imidate **1e** (0.95 mmol, 649 mg) and steroid **2k** (0.5 mmol, 208 mg) were reacted according to the general procedure. After chromatography, glucoside **3k** was isolated as a syrup (370 mg, 79% yield, α/β = 2.2:1); ^1^H NMR (400 MHz, CDCl~3~): δ 7.40--7.10 (m, 29H), 5.00 (d, *J* = 10.8 Hz, 1H), 4.93 (d, *J* = 3.4 Hz, 1.45H), 4.87--4.50 (m, 7.25H), 4.46 (d, *J* = 11.5 Hz, 2H), 4.39 (dd, *J* = 15.0, 7.4 Hz, 1H), 3.99 (t, *J* = 9.3 Hz, 1H), 3.88 (d, *J* = 9.3 Hz, 1H), 3.76--3.34 (m, 9.25H), 2.03--1.91 (m, 1.45H), 1.91--0.82 (m, 40.6H), 0.82 (s, 4.35H), 0.79 (d, *J* = 6.3 Hz, 4.35H), 0.76 (s, 4.35H), 0.64 (d, *J* = 7.7 Hz, 1.45H); ^13^C NMR (101 MHz, CDCl~3~): δ 139.0, 138.32, 138.31, 138.0, 128.5, 128.41, 128.38, 128.2, 128.1, 128.0, 127.90, 127.87, 127.80, 127.72, 127.69, 127.57, 109.3, 94.8, 82.2, 80.9, 78.0, 77.9, 76.2, 75.7, 75.1, 73.5, 73.1, 70.0, 68.7, 66.9, 62.2, 56.3, 54.3, 45.1, 41.6, 40.6, 40.1, 36.9, 35.8, 35.1, 32.3, 31.8, 31.4, 30.3, 28.8, 28.6, 27.4, 21.1, 17.2, 16.5, 14.6, 12.4.

### 6-*O*-(2′,3′,4′,6′-Tetra-*O*-benzyl-α-mannopyranosyl)-(1-6)-1,2:3,4-di-*O*-isopropylidene-α-[d]{.smallcaps}-galactopyranose (**3l**)^[@ref71]^ {#sec3-3-12}

Mannosyl ester **1a** (0.95 mmol, 612 mg) and galactose **2f** (0.5 mmol, 130 mg) were reacted according to the general procedure. After chromatography, glucoside **3l** was isolated as a syrup (149 mg, 38% yield); ^1^H NMR (400 MHz, CDCl~3~): δ 7.41--7.10 (m, 20H), 5.52 (d, *J* = 5.0 Hz, 1H), 5.02 (d, *J* = 1.6 Hz, 1H), 4.86 (d, *J* = 10.8 Hz, 1H), 4.75--4.65 (m, 3H), 4.63--4.57 (m, 3H), 4.55--4.46 (m, 2H), 4.31 (dd, *J* = 5.0, 2.4 Hz, 1H), 4.15 (dd, *J* = 7.9, 1.8 Hz, 1H), 4.02 (t, *J* = 9.1 Hz, 1H), 3.96 (td, *J* = 6.6, 1.5 Hz, 1H), 3.91 (dd, *J* = 9.4, 3.1 Hz, 1H), 3.83 (dd, *J* = 2.9, 2.0 Hz, 1H), 3.81--3.74 (m, 3H), 3.74--3.67 (m, 2H), 1.50 (s, 3H), 1.43 (s, 3H), 1.32 (s, 3H), 1.32 (s, 3H); ^13^C NMR (101 MHz, CDCl~3~): δ 138.6, 138.50, 138.45, 138.4, 128.3, 128.1, 127.8, 127.64, 127.60, 127.56, 127.50, 127.46, 109.4, 108.6, 97.2, 96.4, 80.1, 75.1, 74.9, 74.5, 73.3, 72.3, 72.1, 70.9, 70.7, 70.6, 69.1, 65.3, 65.2, 26.2, 26.0, 24.9, 24.6.

### (3β,5α)-3-\[(2,3,4,6-Tetra-*O*-benzyl-α-mannopyranosyl)oxy\]androstan-17-one (**3m**) {#sec3-3-13}

Method A: starting from α-mannosyl ester **1f** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). α-Mannosyl ester **1f** (0.95 mmol, 612 mg) and steroid **2j** (0.5 mmol, 145 mg) were reacted according to the general procedure. After chromatography, glucoside **3m** was isolated as a syrup (280 mg, 69% yield); ^1^H NMR (400 MHz, CDCl~3~): δ 7.41--7.12 (m, 20H), 5.01 (s, 1H), 4.88 (d, *J* = 10.7 Hz, 1H), 4.73 (dd, *J* = 23.3, 12.5 Hz, 2H), 4.68--4.60 (m, 3H), 4.52 (dd, *J* = 14.8, 11.4 Hz, 2H), 3.97--3.89 (m, 2H), 3.89--3.84 (m, 1H), 3.82--3.70 (m, 3H), 3.60--3.45 (m, 1H), 2.43 (dd, *J* = 19.2, 8.6 Hz, 1H), 2.05 (dd, *J* = 19.0, 9.3 Hz, 1H), 1.96--1.87 (m, 1H), 1.83--1.65 (m, 4H), 1.59--1.45 (m, 2H), 1.36--1.18 (m, 8H), 1.07 (d, *J* = 12.1 Hz, 1H), 1.01--0.87 (m, 3H), 0.85 (s, 3H), 0.79 (s, 3H), 0.70--0.62 (m, 1H); ^13^C NMR (101 MHz, CDCl~3~): δ 221.5, 138.7, 138.54, 138.49, 128.38, 128.36, 128.29, 128.1, 127.9, 127.73, 127.66, 127.6, 127.54, 127.47, 95.9, 80.4, 76.0, 75.23, 75.21, 75.16, 73.3, 72.6, 72.1, 71.8, 69.5, 54.4, 51.4, 47.8, 44.9, 36.8, 35.9, 35.8, 35.1, 31.6, 30.9, 28.4, 27.5, 21.8, 20.5, 13.9, 12.3; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~53~H~64~O~7~Na^+^ 835.4544; found 835.4537.

Method B: starting from β-mannosyl ester **1f** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). β-Mannosyl ester **1f** (0.95 mmol, 612 mg) and steroid **2j** (0.5 mmol, 145 mg) were reacted according to the general procedure. After chromatography, glucoside **3m** was isolated as a syrup (276 mg, 68% yield).

Method C: starting from α-glucosyl chloride **1o** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). α-Glucosyl chloride **1o** (0.95 mmol, 530 mg) and steroid **2j** (0.5 mmol, 145 mg) were reacted according to the general procedure. After chromatography, glucoside **3m** was isolated as a syrup (179 mg, 44% yield).

### 5-Methyl-2′,3′-di-*O*-acetate-5′-*O*-(2,3,4,6-tetra-*O*-benzyl-α/β-glucopyranosyl)uridine (**3n**) {#sec3-3-14}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and nucleoside **2n** (0.5 mmol, 171 mg) were reacted according to the general procedure. After chromatography, glucoside **3n** was isolated as a syrup (203 mg, 47% yield, α/β = 5/1); ^1^H NMR (400 MHz, CDCl~3~): δ 9.41 (s, 1H), 9.08 (s, 0.2H), 7.64 (s, 0.2H), 7.37--7.15 (m, 24H), 7.12 (s, 1H), 6.42 (d, *J* = 8.0 Hz, 0.2H), 6.14 (d, *J* = 6.2 Hz, 1H), 5.58 (t, *J* = 12.5 Hz, 0.2H), 5.43--5.34 (m, 0.4H), 5.34--5.22 (m, 2.2H), 5.00 (d, *J* = 1.1 Hz, 0H), 4.94--4.42 (m, 12H), 4.33--4.17 (m, 1.6H), 4.08--3.94 (m, 2.6H), 3.91 (dd, *J* = 9.1, 2.6 Hz, 1.2H), 3.84--3.71 (m, 5H), 3.69--3.63 (m, 1H), 3.59 (dd, *J* = 9.3, 2.3 Hz, 0.2H), 2.17 (s, 0.6H), 2.11 (s, 3.6H), 2.08 (d, *J* = 5.6 Hz, 3H), 1.69 (s, 3.6H); ^13^C NMR (101 MHz, CDCl~3~): δ 169.8, 169.6, 163.6, 150.6, 138.4, 138.3, 138.3, 138.1, 134.7, 128.6, 128.52, 128.47, 128.38, 128.36, 128.0, 127.9, 127.8, 127.72, 127.69, 127.6, 111.9, 98.4, 86.0, 81.2, 80.4, 75.3, 74.9, 74.7, 73.4, 72.9, 72.8, 72.7, 72.3, 71.3, 69.0, 66.6, 20.7, 20.5, 12.7; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~48~H~52~N~2~O~13~Na^+^ 887.3362; found 887.3367.

### 5-Methyl-2′,3′-di-*O*-acetate-5′-*O*-(2,3,4,6-tetra-*O*-benzyl-α/β-mannopyranosyl)uridine (**3o**) {#sec3-3-15}

Mannosyl ester **1a** (0.95 mmol, 612 mg) and nucleoside **2n** (0.5 mmol, 171 mg) were reacted according to the general procedure. After chromatography, glucoside **3o** was isolated as a syrup (186 mg, 42% yield, α/β = 4/1); ^1^H NMR (400 MHz, CDCl~3~): δ 8.20 (s, 1H), 8.17 (s, 0.26H), 7.59 (s, 0.26H), 7.49 (s, 1H), 7.36--7.13 (m, 25.2H), 6.26 (d, *J* = 7.1 Hz, 1.26H), 5.47 (dd, *J* = 5.4, 1.7 Hz, 0.26H), 5.43--5.37 (m, 1H), 5.33 (dd, *J* = 5.6, 2.6 Hz, 1H), 4.95--4.77 (m, 5H), 4.73 (d, *J* = 3.6 Hz, 1H), 4.65--4.39 (m, 5H), 4.28 (d, *J* = 2.4 Hz, 1.26H), 4.02--3.89 (m, 2H), 3.84--3.53 (m, 7H), 2.13 (s, 0.82H), 2.12 (s, 3H), 2.08 (s, 3.82H), 1.84 (s, 0.82H), 1.80 (s, 3H); ^13^C NMR (101 MHz, CDCl~3~): δ 167.0, 169.6, 163.9, 151.1, 138.7, 138.4, 138.1, 137.9, 135.2, 128.6, 128.5, 128.43, 128.35, 128.2, 128.02, 127.98, 127.91, 127.8, 127.7, 127.6, 112.4, 97.7, 85.16, 82.19, 81.3, 79.8, 75.8, 74.8, 73.6, 73.5, 73.2, 72.1, 71.5, 71.1, 68.2, 67.5, 20.8, 20.6, 12.3; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~48~H~52~N~2~O~13~Na^+^ 887.3362; found 887.3363.

### 3′-*O*-Acetate-5′-*O*-(2,3,4,6-tetra-*O*-benzyl-α/β-glucopyranosyl)thymidine (**3p**) {#sec3-3-16}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and nucleoside **2o** (0.5 mmol, 142 mg) were reacted according to the general procedure. After chromatography, glucoside **3p** was isolated as a syrup (193 mg, 48% yield, α/β = 3.3/1); ^1^H NMR (400 MHz, CDCl~3~): δ 8.16 (s, 1H), 7.64 (s, 0.3H), 7.55 (s, 1H), 7.41--7.06 (m, 26H), 6.39 (td, *J* = 9.2, 5.4 Hz, 1.3H), 5.29 (d, *J* = 5.9 Hz, 0.3H), 5.19 (d, *J* = 6.1 Hz, 1H), 4.84 (dt, *J* = 26.1, 14.0 Hz, 5H), 4.72 (d, *J* = 3.6 Hz, 1H), 4.61 (dd, *J* = 12.2, 5.6 Hz, 3H), 4.46 (dd, *J* = 11.3, 4.1 Hz, 2.3H), 4.32--4.21 (m, 0.6H), 4.17 (s, 1H), 3.98 (dd, *J* = 10.6, 2.5 Hz, 1H), 3.87--3.44 (m, 9H), 3.42--3.34 (m, 0.3H), 2.35 (dd, *J* = 13.7, 5.1 Hz, 1.3H), 2.16--2.03 (m, 4.9H), 1.84 (s, 0.9H), 1.80 (s, 2.7H). ^13^C NMR (101 MHz, CDCl~3~): δ 170.6, 163.8, 150.8, 138.5, 138.02, 137.98, 137.8, 135.0, 128.6, 128.50, 128.45, 128.2, 128.1, 128.0, 127.9, 127.82, 127.79, 127.73, 112.1, 97.5, 84.2, 83.3, 82.1, 79.8, 75.7, 75.3, 75.1, 73.6, 73.5, 71.0, 68.2, 68.0, 37.5, 21.0, 12.2. HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~46~H~50~N~2~O~11~Na^+^ 829.3307; found 829.3296.

### 3′-*O*-Acetate-5′-*O*-(2,3,4,6-tetra-*O*-benzyl-α/β-mannopyranosyl)thymidine (**3q**) {#sec3-3-17}

Mannosyl ester **1a** (0.95 mmol, 612 mg) and nucleoside **2o** (0.5 mmol, 142 mg) were reacted according to the general procedure. After chromatography, glucoside **3q** was isolated as a syrup (153 mg, 38% yield, α/β = 5/1); ^1^H NMR (400 MHz, CDCl~3~): δ 9.25 (s, 1H), 8.84 (s, 0.2H), 7.60 (s, 0.2H), 7.42--7.13 (m, 24H), 7.10 (s, 1H), 6.43 (dd, *J* = 9.4, 5.4 Hz, 0.2H), 6.28 (dd, *J* = 9.1, 5.3 Hz, 1H), 5.36 (d, *J* = 5.4 Hz, 0.2H), 5.09 (d, *J* = 5.9 Hz, 1H), 4.96 (s, 1.2H), 4.88 (d, *J* = 10.7 Hz, 1.2H), 4.79 (d, *J* = 3.4 Hz, 2H), 4.72--4.38 (m, 7H), 4.20--4.13 (m, 1.2H), 4.08 (t, *J* = 9.5 Hz, 1H), 4.00 (dd, *J* = 10.8, 2.7 Hz, 1H), 3.84--3.65 (m, 6H), 3.59 (d, *J* = 9.4 Hz, 1.2H), 3.45 (dt, *J* = 13.4, 6.9 Hz, 0.4H), 2.25 (dd, *J* = 14.0, 5.1 Hz, 1.2H), 2.14--2.03 (m, 4H), 1.67 (s, 3.6H). ^13^C NMR (101 MHz, CDCl~3~): δ 170.5, 163.8, 150.5, 138.3, 138.10, 138.07, 138.01, 134.6, 128.6, 128.51, 128.47, 128.38, 128.2, 127.9, 127.8, 127.7, 127.6, 127.5, 111.3, 98.1, 84.7, 83.4, 79.1, 75.3, 75.2, 74.9, 73.4, 72.7, 72.6, 72.4, 68.8, 67.3, 37.5, 21.0, 12.8. HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~46~H~50~N~2~O~11~Na^+^ 829.3307; found 829.3310.

### 5′-*O*-(2,3,4,6-Tetra-*O*-benzyl-α/β-glucopyranosyl)zidovudine (**3r**) {#sec3-3-18}

Glucosyl ester **1a** (0.95 mmol, 612 mg) and nucleoside **2p** (0.5 mmol, 134 mg) were reacted according to the general procedure. After chromatography, glucoside **3r** was isolated as a syrup (134 mg, 34% yield, α/β = 3/1); ^1^H NMR (400 MHz, CDCl~3~): δ 9.02 (s, 1H), 7.51 (s, 0.34H), 7.44 (s, 1H), 7.38--7.06 (m, 27H), 6.23 (t, *J* = 6.3 Hz, 1H), 6.16 (t, *J* = 6.3 Hz, 0.34H), 4.96--4.69 (m, 7H), 4.62--4.38 (m, 5H), 4.27--4.18 (m, 1.34H), 4.12--3.99 (m, 2H), 3.86 (dd, *J* = 11.2, 3.4 Hz, 2H), 3.75--3.56 (m, 7H), 3.54--3.47 (m, 0.34H), 3.41 (t, *J* = 8.4 Hz, 0.34H), 2.44--2.35 (m, 1.34H), 2.22 (dt, *J* = 22.0, 7.5 Hz, 1.34H), 1.87 (s, 0.9H), 1.82 (s, 1H); ^13^C NMR (101 MHz, CDCl~3~): δ 163.9, 150.4, 138.5, 138.0, 137.9, 137.7, 135.3, 128.6, 128.52, 128.49, 128.2, 128.14, 128.1, 128.0, 127.9, 127.8, 127.6, 111.7, 97.6, 84.5, 82.5, 82.1, 79.9, 75.7, 75.3, 75.1, 73.6, 73.5, 71.0, 68.3, 67.3, 60.2, 37.7, 12.3; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~44~H~47~N~5~O~9~Na^+^ 812.3266; found 812.3264.

### 5′-*O*-(2,3,4,6-Tetra-*O*-benzyl-α/β-mannopyranosyl)zidovudine (**3s**) {#sec3-3-19}

Mannosyl ester **1a** (96 mg, 0.50 mmol) and nucleoside **2p** (0.5 mmol, 134 mg) were reacted according to the general procedure. After chromatography, glucoside **3s** was isolated as a syrup (162 mg, 41% yield, α/β = 2.1/1); ^1^H NMR (400 MHz, CDCl~3~): δ 9.26 (d, *J* = 35.8 Hz, 1H), 8.92 (d, *J* = 32.9 Hz, 0.3H), 7.50 (s, 0.3H), 7.43--7.13 (m, 26H), 7.10 (s, 1H), 6.28 (s, 0.3H), 6.10 (t, *J* = 6.5 Hz, 1H), 4.95 (s, 1H), 4.92--4.71 (m, 4H), 4.67--4.41 (m, 8H), 4.29--4.24 (m, 0.3H), 4.18 (d, *J* = 10.2 Hz, 0.3H), 4.14--3.93 (m, 4H), 3.90 (dd, *J* = 10.9, 2.7 Hz, 1.3H), 3.81--3.57 (m, 8H), 3.54--3.42 (m, 0.6H), 2.32--2.24 (m, 1.3H), 1.96 (dt, *J* = 13.8, 7.1 Hz, 1.3H), 1.72 (s, 3H), 1.62 (s, 1H); ^13^C NMR (101 MHz, CDCl~3~): δ 163.8, 150.2, 138.14, 138.09, 138.00, 135.2, 128.6, 128.50, 128.48, 128.46, 128.42, 128.38, 128.21, 127.8, 127.7, 127.6, 111.0, 98.3, 85.2, 82.6, 79.4, 75.3, 75.2, 74.9, 73.5, 72.7, 72.4, 69.1, 67.1, 61.31, 37.6, 12.8; HRMS (ESI) *m*/*z*: \[M + Na\]^+^ calcd for C~44~H~47~N~5~O~9~Na^+^ 812.3266; found 812.3274.
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